Stock Analiz

electroCore, Inc. ECOR

Biotechnology: Electromedical & Electrotherapeutic Apparatus · IPO 2018 · data as of November 13, 2026

$5.25Market cap $48M
Open the interactive analysis →

electroCore, Inc. (ECOR) is a healthcare company listed in the US with a market value of about $48M. In the twelve months to September 30, 2026 it had revenue of $38M and net income of -$13M, a net margin of -33.5%.

Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of 56% a year, a 5-year average ROIC of -125%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 37% below the current price.

About electroCore

electroCore is listed in the US and classified in biotechnology: electromedical & electrotherapeutic apparatus, IPO year 2018. Revenue went from $811457 in 2017 to $32M in 2025, growth of about 58.3% a year. It was profitable in 0 of the last 9 years in our data. Its share count rose by 79% over three years (dilution for shareholders).

Score: 1.2 / 5

Value0/5
Future growth4/5
Track record2/5
Financial health0/5
Shareholder returns0/5

Checks passed

  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • 5-year revenue growth above 8% a year
  • ROE above 15%

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year
  • 5-year average ROIC above 12%

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S1.3
P/B—
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-22.5%
Shareholder yield0.0%
Intrinsic value vs. price−37%

Growth and quality

Revenue growth (1 yr)27.2%
Revenue growth (5 yrs, per year)55.7%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-156.4%
ROIC (5-yr avg.)-125.1%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 9 years

Fiscal yearTTM202520242023202220212020201920182017
Revenue$38M$32M$25M$16M$9M$5M$3M$2M$992953$811457
Net income-$13M-$14M-$12M-$19M-$22M-$17M-$24M-$45M-$56M-$36M
Free cash flow-$11M-$8M—-$15M———-$45M-$47M-$25M
EPS (diluted)$-1.39$-1.65$-1.59$-3420.00$-4.69$-4.36$-0.60$-1.54$-1.19—
Net margin-33.5%-43.6%-47.2%-117.5%-257.9%-315.9%-672.6%-1888.8%-5621.7%-4410.9%
ROIC—-117.4%-103.3%-229.5%-124.3%-51.0%-91.2%-139.1%-61.8%—

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Is electroCore stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 37% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does electroCore pay a dividend?

Not currently.

Is electroCore a good stock to buy?

We do not give buy or sell advice. electroCore scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.